Award
National Institute of Allergy and Infectious Diseases 5R01AI167009-05
In vivo CRISPR engineering of B cells to produce anti-HIV broadly neutralizing antibodies using novel nanoparticles
Recipient
UNIV OF MASSACHUSETTS MED SCH WORCESTER
Award Amount
$717,470.00
Ceiling
$717,470.00
Awarded
June 09, 2026
Identifier
5R01AI167009-05
NIH awarded a research grant to develop gene editing therapies for HIV using CRISPR and novel nanoparticles targeting B cells and hematopoietic stem cells.
Description
This is a research grant opportunity from NIH focusing on gene therapy and nanoparticle delivery systems for HIV treatment. The project involves in vivo genetic engineering of B cells and hematopoietic stem cells using novel nanoparticles. The award amount is approximately $717,470 for the fiscal year 2026. The project aims to develop scalable and equitable gene editing therapies.